Form D — Phio Pharmaceuticals Corp.
0001123292-25-000029 · filed Jan 28, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $5,000,010
- Reported amount sold
- $208,334
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Phio Pharmaceuticals Corp.
- CIK
- 1533040
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 411 SWEDELAND ROAD
KING OF PRUSSIA, PA 19406 - Phone
- 760-943-1088
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Robert J. Bitterman · DirectorMarlborough, MA Find on LinkedIn ↗
-
Patricia A. Bradford · DirectorMarlborough, MA Find on LinkedIn ↗
-
Robert Ferrara · DirectorMarlborough, MA Find on LinkedIn ↗
-
Jonathan Freeman · DirectorMarlborough, MA Find on LinkedIn ↗
-
Curtis Lockshin, Ph.D. · DirectorMarlborough, MA Find on LinkedIn ↗
-
Robert Infarinato · Executive OfficerMarlborough, MA Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗